Nitin Jain, MD, associate professor in the department of leukemia, University of Texas MD Anderson Cancer Center, is the guest of honor to provide a comprehensive and simplified overview of the major advances in chronic lymphocytic leukemia over the past two decades. Dr. Jain talks mutations and time to treatment, prognostic markers, BTK inhibitors, combination regimens, current research, toxicities, cost, and a host of controversies with trial comparator arms, drug similarities, and MRD.Check out Chadi’s website for all Healthcare Unfiltered episodes and other content. www.chadinabhan.com/Watch all Healthcare Unfiltered episodes on Youtube. www.youtube.com/channel/UCjiJPTpIJdIiukcq0UaMFsA